story of the week
Efficacy and Tolerability of Vesicular Monoamine Transporter Type 2 Inhibitors for Tic Disorders
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Movement Disorders: Official Journal of the Movement Disorder Society
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Meta-Analysis: Efficacy and Tolerability of Vesicular Monoamine Transporter Type 2 Inhibitors in the Treatment of Tic Disorders
Mov. Disord. 2022 Apr 01;37(4)684-693, E Behling, LC Farhat, A Landeros-Weisenberger, MH BlochFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.